Trending Stocks: Lockheed Martin to Get Trump Boost? Plus the Latest on ConocoPhillips, Netflix, Pfizer, and More

eBay Inc (NASDAQ:EBAY) is in the spotlight after analyst Colin Sebastian of Baird commented that his research tracker shows that the e-commerce company likely had a solid month of October. With that said, the analyst doesn’t expect eBay’s growth to jump significantly until management rolls out a new format/product next year. Sebastian has a $35 price target and an ‘Outperform’ rating on the auction giant. 58 funds that we track were long eBay Inc (NASDAQ:EBAY) at the end of June, up one from the end of the previous quarter.

Pfizer Inc. (NYSE:PFE) shares are higher after the European Commission approved the drug giant’s IBRANCE in combination with another drug, Arimidex, for the treatment of a certain common form of breast cancer. Given that breast cancer is a large market, many traders expect strong demand for the drug. In addition, Pfizer is also trending after Reuters reported that the company is considering a potential spin-off or sale of its consumer health segment for as much as $14 billion. The division includes popular brands such as Advil and lip balm Chapstick. The number of funds in our system with holdings in Pfizer Inc. (NYSE:PFE) fell by 25 quarter-over-quarter to 94 at the end of June.

Netflix, Inc. (NASDAQ:NFLX) is trending after David Miller of Loop Capital hiked his price target on the stock to $151 from $133 per share. Miller did so after raising his subscriber add assumptions for the internet streamer, with the analyst estimating that Netflix will have 53.7 million subscribers domestically at the end of 2017, up from the previous 53.6 million estimate. Miller also thinks that Netflix’s international subscriber base will grow to 55.8 million as of the same time period, versus his previous estimate of 54.8 million. Andreas Halvorsen‘s Viking Global cut its stake in Netflix, Inc. (NASDAQ:NFLX) by 22% to 6.28 million shares during the second quarter.

Disclosure: None